Search Medical Condition
Please enter condition
Please choose location from dropdown
Clear Trial Filters

Liuying Township, Taiwan Clinical Trials

A listing of Liuying Township, Taiwan clinical trials actively recruiting patients volunteers.

RESULTS

Found (763) clinical trials

If you are eligible, you will be randomly assigned to receive either an experimental medication, or no active treatment. Your participation in the study will last 8 to 10 weeks. You will be routinely monitored for safety and to see if the study treatment is working. All study-related procedures will …

Phase

The Memory Health Center at Summit Research Network, is enrolling participants in a new mild Alzheimer’s clinical trial. This trial will evaluate the safety and effectiveness of the study medication, azeligaron in the treatment of mild Alzheimer’s disease in patients who also have glucose intolerance or Type 2 Diabetes: those …

Phase

Study participation will last about a year.   Following a screening period of up to 6 weeks, qualified participants will be randomly assigned to the oral investigational medication, C0R388, or a placebo (an inactive substance).   During the treatment period, the participants will visit the research center 9 times over a 48 …

Phase

People with either a new diagnosis of glioblastoma or with evidence that their tumor has returned or started to grow again may be eligible.  This trial is studying multiple treatment options, with the results of molecular testing on the tumor determining which arm(s) a person would qualify for.  This trial …

Phase

Study With an Autologous Dermo-epidermal Skin Substitute for the Treatment of Burns in Adults

This multicentre phase IIb clinical trial will target adult patients with severe burns to elucidate the benefit of a tissue-engineered autologous skin substitute for the patient group with the highest mortality rates. Particular emphasis, apart from safety, will be placed on efficacy, including the ratio of covered surface area to …

Phase

NA-83 Atazanavir and Dexamethasone Combination Therapy for the Treatment of COVID-19 Infection

The clinical Phase 2/3 evaluates the safety and efficacy of NA-831 alone, and a combination therapy comprises NA-831 with an anti-viral drug Atazanavir, NA-831 with an anti-inflammatory drug, Dexamethasone and a potential synergy between Atazanavir and Dexamethasone. NA-831 is also known as Traneurocin is a neuroprotective drug that is in …

Phase

An Active and Placebo-Controlled Study of Brazikumab in Participants With Moderately to Severely Active Crohn's Disease

This study seeks to evaluate the safety and efficacy of brazikumab versus placebo (Stage I) and versus an active comparator (Stage 2) in participants with moderately to severely active CD and will include assessments of clinical response as demonstrated by improvement of symptoms and colonic mucosal appearance as observed on …

Phase

Investigating a Vaccine Against COVID-19

There will be 6 study groups and it is anticipated that a total of 10,260 volunteers will be enrolled. Group 1 is adults aged 56-69 years; group 2 is adults 70 years and over; group 3 is children aged 5-12 years; groups 4 and 6 are adults over the age …

Phase

PF-06651600 for the Treatment of Alopecia Areata

This is a global Phase 2b/3 study to evaluate the safety and effectiveness of an investigational study drug (called PF-06651600) in adults and adolescents (12 years and older) who have 50% or greater scalp hair loss. The study is placebo-controlled, meaning that some patients entering the study will not receive …

Phase

Treatment of Intracerebral Hemorrhage in Patients on Non-vitamin K Antagonist

Novel, non-vitamin K antagonist oral anticoagulants (NOAC) target selected players in the coagulation cascade as the direct thrombin inhibitor dabigatran and the factor Xa-inhibitors apixaban and rivaroxaban. Intracerebral hemorrhage (ICH) is the most feared complication of NOAC treatment (NOAC-ICH). Outcome of NOAC-ICH can be devastating and is a major cause …

Phase